Sex differences in colorectal cancer mortality in Europe, 1955-1996

European Journal of Cancer Prevention

Volumn 9, Issue 2, 2000, Pages 99-104

  Fernandez, E ^a,b,e   Bosetti, C ^b   La Vecchia, C ^b,c   Levi, F ^d   Fioretti, F ^b   Negri, E ^b  

^a Institut Universitari de Salut Publica de Catalunya   (Spain)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d Registre Vaudois des Tumeurs   (Switzerland)

^e UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Colon cancer; Mortality; Rectal cancer; Sex ratio; Temporal trends

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; COLORECTAL CANCER; ENVIRONMENTAL EXPOSURE; EUROPE; FEMALE; HORMONE ACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SEX RATIO;

ADULT; AGED; COLORECTAL NEOPLASMS; DIET; ENVIRONMENTAL EXPOSURE; EUROPE; EXERCISE; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS; SEX RATIO; STATISTICS, NONPARAMETRIC;

EID: 0034118684     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-200004000-00005     Document Type: Article

References (37)

1. Boyle P (1989). Relative value of incidence and mortality data in cancer research. Recent Results Cancer Res 114: 41-63.
2. Chu KC, Tarone RE, Chow W-H, Hankey BF, Ries LAG (1994). Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990. J Natl Cancer Inst 86: 997-1006.
3. Decosse JJ, Ngoi S-S, Jacobson JS, Cennerazzo WJ (1993). Gender and colorectal cancer. Eur J Cancer Prev 2: 105-15.
4. Doll R, Smith PG (1982). Comparison between registries: age-standardized rates. In Cancer Incidence in Fire Continents, Volume IV (eds Waterhouse JAH, Muir CS, Shanmugaratnam K, et al.); IARC Scientific Publication No. 42, Lyon, pp. 671-5.
5. Dos Santos Silva I, Swerdlow AJ (1996). Sex differences in time trends of colorectal cancer in England and Wales: the possible effect of female hormonal factors. Br J Cancer 73: 692-7.
6. Dowd JE (1999). An overview of relevant data sources in the former USSR for studies in demographic trends, aging and noncommunicable disease problems. World Health Stat Q 45: 8-74.
7. Dubrow R, Bernstein J, Holdford TR (1993). Age-period-cohort modelling of large-bowel-cancer incidence by anatomic sub-site and sex in Connecticut. Int J Cancer 53: 907-12.
8. Franceschi S, La Vecchia C (1998a). Colorectal cancer and hormone replacement therapy: an unexpected finding. Eur J Cancer Prev 7: 427-38.
9. Franceschi S, La Vecchia C (1998b). Oral contraceptives and colorectal tumors. A review of epidemiologic studies. Contraception 58: 335-43.
10. Grilli R, Apolone G, Marsoni S, et al. (1991). The impact of patient management guidelines on the care of breast, colorectal, and ovarian cancer patients in Italy. Med Care 29: 50-63.
11. Harvard Report on Cancer Prevention (1999). Volume 3: Prevention of colon cancer in the United States. Cancer Causes Control 10: 167-80.
12. Hoel DG, Davis DL, Miller AB, Sondik EJ, Swerdlow AJ (1992). Trends in cancer mortality in 15 industrialized countries, 1969-1986. J Natl Cancer Inst 84: 313-20.
13. Hoover RN (1998). Cancer prevention: better late than never? Ann Intern Med 128: 771-2.
14. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson EN, Baylin SB (1994). Methylation of the oestrogen receptor CpG islands links ageing and neoplasia in human colon. Nature Genet 7: 536-40.
15. International Agency for Research on Cancer (1999). Hormonal contraception and postmenopausal hormonal therapy. IARC Monogr Eral Carcinog Risks Hum 72.
16. Jensen OM (1984). Different age and sex relationship for cancer of subsites of the large bowel. Br J Cancer 50: 825-9.
17. La Vecchia C, Negri E, Levi F, Decarli A, Boyle P (1998). Cancer mortality in Europe: effects of age, cohort of birth and period of death. Eur J Cancer 34: 118-41.
18. Levi F, La Vecchia C, Franceschi S, Te V-C (1991). Morphologic analysis of digestive cancers from the registry of Vaud, Switzerland. Br J Cancer 63: 567-72.
19. Levi F, La Vecchia C, Lucchini F, Negri E (1992). Trends in cancer mortality sex ratios in Europe, 1950-1989. World Health Stat Q 45: 117-64.
20. Levi F, Lucchini F, Boyle P, Negri E, La Vecchia C (1998). Cancer incidence and mortality in Europe, 1988-92. J Epidemiol Biostat 3: 295-373.
21. Lointier P, Wildrick DM, Boman BM (1992). The effects of steroid hormones on a human colon cancer cell line in vitro. Anticancer Res 12: 1327-30.
22. McMichael AJ, Giles GG (1994). Colorectal cancer. Cancer Surv 19: 77-98.
23. McMichael AJ, Potter JD (1980). Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis. J Natl Cancer Inst 65: 1201-7.
24. McTiernan A, Ulrich C, Slate S, Potter J (1998). Physical activity and cancer etiology: associations and mechanisms. Cancer Causes Control 9: 487-509.
25. Makkonen K, Hemminki E (1991). Different contraceptive practices: use of contraceptives in Finland and other Nordic countries in the 1970s and 1980s. Scand J Soc Med 19: 32-38.
26. Mella J, Biffin A, Radcliffe AG, Stamatakis JD, Steele RJ (1997). Population-based audit of colorectal cancer management in two UK health regions. Colorectal Cancer Working Group, Royal College of Surgeons of England Clinical Epidemiology and Audit Unit. Br J Surg 84: 1731-6.
27. Nicholson WJ, Davis DL (1990). Analyses of changes in the ratios of male-to-female cancer mortality. A hypothesis-generating exercise. Ann NY Acad Sci 609: 290-7.
28. Percy C, Staneck E, Gloeckler L (1981). Accuracy of cancer death certificates and its effects on cancer mortality statistics. Am J Public Health 71: 242-50.
29. Potter JD, Slattery ML, Bostick RM, Gapstur SM (1993). Colon cancer: a review of the epidemiology. Epidemiol Rev 15: 499-545.
30. Reddy BS, Watanabe K, Weisburger JH, Wynder EL (1977). Promoting effect of bile acids on colon carcinogenesis in germ-free and conventional F344 rats. Cancer Res 37: 3238-42.
31. Ruiz MT, Verbrugge LM (1997). A two way view of gender bias in medicine. J Epidemiol Community Health 51: 106-19.
32. Seidell JC (1997). Time trends in obesity: an epidemiological perspective. Hormone Metab Res 29: 155-8.
33. Singh P, Dai B, Yallampalli C, Xu Z (1994). Expression of IGF-II and IGF-binding proteins by colon cancer cells in relation to growth response to IGFs. Am J Physiol 267: G608-17.
34. Topo P, Klaukka T, Hemminki E, Uutela A (1991). Use of hormone replacement therapy in 1976-89 by 45-64 year old Finnish women. J Epidemiol Community Health 45: 277-80.
35. Toulemon L, Leridon H (1998). Contraceptive practices and trends in France. Family Plann Perspect 30: 114-20.
36. Townsend J (1998). Hormone replacement therapy: assessment of present use, costs and trends. Br J Gen Pract 48: 955-8.
37. World Health Organization (1977). Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, 9th Revision. WHO, Geneva.